It is not approved for human consumption, veterinary use, therapeutic applications, or medical treatments
The FDA approved lorcaserin as an anti-obesity drug in 2012, but in February 2020, the FDA requested the voluntary withdrawal of Belviq from the U.S
In pregnant rabbits given 0.2, 2, 22, 156, or 260 mcg/kg/day exenatide during fetal organogenesis, irregular fetal skeletal ossifications were observed at 2 mcg/kg/day, a dose yielding systemic exposure up to 12-times the human exposure from the MRHD of BYETTA based on AUC comparison
The class 1 variant is a rare and severe one, associated with chronic non-spherocytic hemolytic anemia
Similar content being viewed by others Main The pioneering work of William C
Serum gamma-glutamyltransferase: linking together environmental pollution, redox equilibria and progression of atherosclerosis